• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    1.66 Down 0.02(1.19%) Feb 12, 4:00PM EST
    Prev Close:1.68
    Open:1.69
    Bid:N/A
    Ask:1.91 x 700
    1y Target Est:6.00
    Beta:2.36738
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:1.60 - 1.74
    52wk Range:1.50 - 5.24
    Volume:506,963
    Avg Vol (3m):1,450,900
    Market Cap:201.36M
    P/E (ttm):N/A
    EPS (ttm):-0.45
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IDRA

    Comparison

    Symbol% ChgMkt Cap
    IDRADown 1.19%201.36M
    PFEUp 0.79%181.25B
    DVAXUp 0.32%728.92M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3,259.48
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.44
    Quarterly EPS Est (Dec-15) :-0.11
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback